Global Aesthetic Injectable Market Growth, Size, Trends Analysis - By Type, By Application, By End-User Segment Forecast to 2034

Description

Aesthetic Injectable Market Introduction and Overview

According to SPER market research, 'Aesthetic Injectable Market Size- By Type, By Application, By End-User - Regional Outlook, Competitive Strategies and Segment Forecast to 2034' state that the Global Aesthetic Injectable Market is predicted to reach 39.72 billion by 2034 with a CAGR of 12.39%.

Aesthetic injectables have revolutionized cosmetic dermatology and plastic surgery by offering minimally invasive methods of facial rejuvenation and contouring. Botulinum toxin (Botox, Dysport, and Xeomin) and dermal fillers are the most often used injectables. They are often used to eliminate wrinkles, restore lost volume, increase facial symmetry, and improve skin texture without the need for surgery.

Restraints: The global aesthetic injectable market has several obstacles that hinder its growth and usage. The strict regulatory system that oversees the authorization and distribution of injectables is a significant barrier. Stringent safety and efficacy criteria are enforced by regulatory authorities such as the United States Food and Drug Administration and the European Medicines Agency, which can lead to product delays and higher manufacturing costs.

Scope of the Report:

Report Metric Details

Market size available for years 2021-2034

Base year considered 2024

Forecast period 2025-2034

Segments covered By Type, By Application, By End-User.

Regions covered

North America, Latin America, Asia-Pacific, Europe, and Middle East & Africa.

Companies Covered

Ipsen Pharma, AbbVie Inc., Merz GmbH and Co. KGaA, Galderma, Prollenium Medical Technologies Inc., Suneva Medical Inc., Sinclair Pharma, Medytox Inc., Revance Therapeutics Inc.

Aesthetic Injectable Market Segmentation:

By Type: Based on the Type, Global Aesthetic Injectable Market is segmented as; Collagen, Hyaluronic Acid, Botulinum Toxin, Polylactic Acid, Polymethyl-Methacrylate Microspheres (PMMA), Calcium Hydroxylapatite, Fat Injections, Others.

By Application: Based on the Application, Global Aesthetic Injectable Market is segmented as; Facelift, Facial Line Correction, Acne Scar Treatment, Wrinkle Reduction, Lip Enhancement, Lipoatrophy Treatment, Others.

By End-User: Based on the End-User, Global Aesthetic Injectable Market is segmented as; Hospitals And Ambulatory Surgery Centres, Dermatology And Cosmetic Clinics, Others.

By Region: This research also includes data for North America, Latin America, Asia-Pacific, Europe, Middle East & Africa.

Product Code: HLCA2590

1. Introduction

1.1. Scope of the report
1.2. Market segment analysis

2. Research Methodology

2.1. Research data source
- 2.1.1. Secondary Data
- 2.1.2. Primary Data
- 2.1.3. SPERs internal database
- 2.1.4. Premium insight from KOLs
2.2. Market size estimation
- 2.2.1. Top-down and Bottom-up approach
2.3. Data triangulation

3. Executive Summary

4. Market Dynamics

4.1. Driver, Restraint, Opportunity and Challenges analysis
- 4.1.1. Drivers
- 4.1.2. Restraints
- 4.1.3. Opportunities
- 4.1.4. Challenges

5. Market variable and outlook

5.1. SWOT Analysis
- 5.1.1. Strengths
- 5.1.2. Weaknesses
- 5.1.3. Opportunities
- 5.1.4. Threats
5.2. PESTEL Analysis
- 5.2.1. Political Landscape
- 5.2.2. Economic Landscape
- 5.2.3. Social Landscape
- 5.2.4. Technological Landscape
- 5.2.5. Environmental Landscape
- 5.2.6. Legal Landscape
5.3. PORTERs Five Forces
- 5.3.1. Bargaining power of suppliers
- 5.3.2. Bargaining power of buyers
- 5.3.3. Threat of Substitute
- 5.3.4. Threat of new entrant
- 5.3.5. Competitive rivalry
5.4. Heat Map Analysis

6. Competitive Landscape

6.1. Global Aesthetic Injectable Market Manufacturing Base Distribution, Sales Area, Product Type
6.2. Mergers & Acquisitions, Partnerships, Product Launch, and Collaboration in Global Aesthetic Injectable Market

7. Global Aesthetic Injectable Market, By Type 2021-2034 (USD Million)

7.1. Collagen
7.2. Hyaluronic Acid
7.3. Botulinum Toxin
7.4. Polylactic Acid
7.5. Polymethyl-methacrylate Microspheres (PMMA)
7.6. Calcium Hydroxylapatite
7.7. Fat Injections
7.8. Others

8. Global Aesthetic Injectable Market, By Application 2021-2034 (USD Million)

8.1. Facelift
8.2. Facial Line Correction
8.3. Acne Scar Treatment
8.4. Wrinkle Reduction
8.5. Lip Enhancement
8.6. Lipoatrophy Treatment
8.7. Others

9. Global Spinal Implants and Devices Market, By End-User 2021-2034 (USD Million)

9.1. Hospitals & Ambulatory Surgery Centers
9.2. Dermatology & Cosmetic Clinics
9.3. Others

10. Global Aesthetic Injectable Market 2021-2034 (USD Million)

10.1. Global Aesthetic Injectable Market Size and Market Share

11. Global Aesthetic Injectable Market, By Region, 2021-2034 (USD Million)

11.1. Asia-Pacific
- 11.1.1. Australia
- 11.1.2. China
- 11.1.3. India
- 11.1.4. Japan
- 11.1.5. South Korea
- 11.1.6. Rest of Asia-Pacific
11.2. Europe
- 11.2.1. France
- 11.2.2. Germany
- 11.2.3. Italy
- 11.2.4. Spain
- 11.2.5. United Kingdom
- 11.2.6. Rest of Europe
11.3. Middle East and Africa
- 11.3.1. Kingdom of Saudi Arabia
- 11.3.2. United Arab Emirates
- 11.3.3. Qatar
- 11.3.4. South Africa
- 11.3.5. Egypt
- 11.3.6. Morocco
- 11.3.7. Nigeria
- 11.3.8. Rest of Middle-East and Africa
11.4. North America
- 11.4.1. Canada
- 11.4.2. Mexico
- 11.4.3. United States
11.5. Latin America
- 11.5.1. Argentina
- 11.5.2. Brazil
- 11.5.3. Rest of Latin America

12. Company Profile

12.1. Ipsen Pharma
- 12.1.1. Company details
- 12.1.2. Financial outlook
- 12.1.3. Product summary
- 12.1.4. Recent developments
12.2. AbbVie Inc.
- 12.2.1. Company details
- 12.2.2. Financial outlook
- 12.2.3. Product summary
- 12.2.4. Recent developments
12.3. Merz GmbH and Co. KGaA
- 12.3.1. Company details
- 12.3.2. Financial outlook
- 12.3.3. Product summary
- 12.3.4. Recent developments
12.4. Galderma
- 12.4.1. Company details
- 12.4.2. Financial outlook
- 12.4.3. Product summary
- 12.4.4. Recent developments
12.5. Prollenium Medical Technologies Inc.
- 12.5.1. Company details
- 12.5.2. Financial outlook
- 12.5.3. Product summary
- 12.5.4. Recent developments
12.6. Suneva Medical Inc.
- 12.6.1. Company details
- 12.6.2. Financial outlook
- 12.6.3. Product summary
- 12.6.4. Recent developments
12.7. Sinclair Pharma
- 12.7.1. Company details
- 12.7.2. Financial outlook
- 12.7.3. Product summary
- 12.7.4. Recent developments
12.8. Medytox Inc.
- 12.8.1. Company details
- 12.8.2. Financial outlook
- 12.8.3. Product summary
- 12.8.4. Recent developments
12.9. Revance Therapeutics Inc.
- 12.9.1. Company details
- 12.9.2. Financial outlook
- 12.9.3. Product summary
- 12.9.4. Recent developments
12.10. Others